iparomlimab   Click here for help

GtoPdb Ligand ID: 13792

Synonyms: QL-1604 | QL1604
Approved drug
iparomlimab is an approved drug
Compound class: Antibody
Comment: Iparomlimab (QL1604) is a humanized monoclonal antibody against programmed cell death protein 1 (PD-1). It blocks the inhibitory PD-1/PD-L1/2 immune checkpoint.
Classification Click here for help
Compound class Antibody
Approved drug? Yes. China NMPA (2024)
International Nonproprietary Names Click here for help
INN number INN
11840 iparomlimab
Synonyms Click here for help
QL-1604 | QL1604
Database Links Click here for help
Specialist databases
IMGT/mAb-DB 1203
Other databases
GtoPdb PubChem SID 507750425
Search PubMed clinical trials iparomlimab
Search PubMed titles iparomlimab
Search PubMed titles/abstracts iparomlimab